社会医療法人財団慈泉会 相澤病院は、長野県松本市本庄にある医療機関。社会医療法人財団慈泉会が運営する病院である。長野県初の地域医療支援病院で中信地方救急指定病院である。

During the past decade, Aizawa Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Aizawa Hospital" are "Ulcerative Colitis" (3 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Aizawa Hospital" in a lesser frequency.

Most popular intervention types in "Aizawa Hospital" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ontamalimab" (2 trials), "Placebo" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aizawa Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Aizawa Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Aizawa Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Aizawa Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".